Archives
Cholangiocarcinoma Awareness Month
February is Cholangiocarcinoma Awareness Month. The Cholangiocarcinoma Foundation (CCF) invites the community to help educate the public about bile duct…
A single arm phase 2 study of Y-90 SIRT in combination with durvalumab (MEDI 4736) and gemcitabine/cisplatin in locally advanced, unresectable or metastatic intrahepatic cholangiocarcinoma
Study Name A single arm phase 2 study of Y-90 SIRT in combination with durvalumab (MEDI 4736) and gemcitabine/cisplatin in locally advanced,…
Bruce Coppock, Former Vice Chair of the Board of Directors of the Cholangiocarcinoma Foundation, Dies at age 71
Cholangiocarcinoma patient Bruce Coppock leaves behind a legacy of leadership benefiting the Cholangiocarcinoma Foundation Bruce Coppock, Vice Chair of the…
Monthly Scientific Update – December 2022
The Oral Microbiome in Cholangiocarcinoma: A Potential Biomarker that Could Promote Early Detection Kelly Butler, Dr. Reham Abdel-Wahab The human…
Giving Tuesday 2022
Thank you to everyone that participated in Giving Tuesday 2022! Donations Last year on Giving Tuesday, people came together to…
Monthly Scientific Update – November 2022 (A recent study investigated the effects of PD-L1 expression on cancer cells and tumor-infiltrating immune cells in intrahepatic cholangiocarcinoma (CCA))
PD-L1 on Tumor-Infiltrating Immune Cells: A Potential Prognostic Biomarker for Cholangiocarcinoma Kelly Butler, Dr. Reham Abdel-Wahab Patients may develop cancer…
‘Think tank’ of multidisciplinary experts develop proposals to leverage precision medicine in improving cholangiocarcinoma patient outcomes
Cholangiocarcinoma Foundation sponsored C2T2 in Las Vegas with funding from a generous donor Twenty-nine expert scientists and clinicians from the…
Cure Cholangiocarcinoma Think Tank (C2T2)
The Cholangiocarcinoma Foundation has published a white paper from the first Cure Cholangiocarcinoma Think Tank (C2T2 ) meeting, which gathered…
🤚🏻 Five for Friday – Meet Some of CCF's Valued Experts
Home / Blog / [wpbb post:title] Collaboration is essential for cholangiocarcinoma research. This month, join us in appreciating our medical…
🤚🏻 Five for Friday – 6 CCF Accomplished Medical Professionals
Home / Blog / [wpbb post:title] CCF collaborates with many physicians, clinicians, and researchers whose accomplishments in the cholangiocarcinoma field…
Man runs a marathon each month in honor of his wife, who has been diagnosed with rare bile duct cancer twice
Delorean Ostrom's 'Racing for Hope' campaign raises funds to advance cholangiocarcinoma research with proceeds benefiting the Cholangiocarcinoma Foundation SALT LAKE…
Monthly Scientific Update – October 2022 (Breath Tests Could Help Diagnose Cholangiocarcinoma: An Innovative Approach to Early Detection)
Kelly Butler, Dr. Reham Abdel-Wahab Cholangiocarcinoma (CCA) is often detected at an advanced stage that is difficult to treat. Early…